Nicolette N Houreld
Overview
Explore the profile of Nicolette N Houreld including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
636
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mgwenya T, Abrahamse H, Houreld N
Wound Repair Regen
. 2024 Nov;
33(1):e13239.
PMID: 39610015
Diabetes mellitus remains a global challenge to public health as it results in non-healing chronic ulcers of the lower limb. These wounds are challenging to heal, and despite the different...
2.
Hadebe L, Houreld N
Discov Med
. 2024 Oct;
36(189):1987-1997.
PMID: 39463219
Diabetes mellitus (DM) and its associated complications, including diabetic kidney disease, neuropathy, and retinopathy, impose significant challenges on healthcare systems due to their high morbidity, mortality, and associated costs. Existing...
3.
Gumede D, Abrahamse H, Houreld N
Cell Commun Signal
. 2024 Apr;
22(1):244.
PMID: 38671406
Wound healing is a tightly regulated process that ensures tissue repair and normal function following injury. It is modulated by activation of pathways such as the transforming growth factor-beta (TGF-β),...
4.
Leyane T, Jere S, Houreld N
J Biophotonics
. 2023 Nov;
17(2):e202300230.
PMID: 38010362
Treatment of chronic diabetic wounds is an ongoing socio-economic challenge. Dysregulated signalling pathways characterise cells from chronic diabetic wounds. Photobiomodulation (PBM) stimulates healing by eliciting photochemical effects that affect gene...
5.
Kasowanjete P, Abrahamse H, Houreld N
Cells
. 2023 Apr;
12(7).
PMID: 37048153
Diabetic foot ulcers (DFUs) are open chronic wounds that affect diabetic patients due to hyperglycaemia. DFUs are known for their poor response to treatment and frequently require amputation, which may...
6.
George B, Rajendran N, Houreld N, Abrahamse H
Molecules
. 2022 Oct;
27(20).
PMID: 36296460
(RF) has widely been used to treat various ailments, including pain, diabetes, and cancer. Zinc oxide nanoparticles (ZnO NPs) have drawn attention in modern healthcare applications. Hence, we designed this...
7.
Kasowanjete P, Houreld N, Abrahamse H
J Wound Care
. 2022 Oct;
31(10):832-845.
PMID: 36240795
Objective: Current therapies and technologies used to treat hard-to-heal diabetic wounds are limited to a 50% healing rate. The rise in the percentage of lower limb non-traumatic amputations in patients...
8.
Leyane T, Jere S, Houreld N
Int J Mol Sci
. 2022 Jul;
23(13).
PMID: 35806275
Ageing and chronic degenerative pathologies demonstrate the shared characteristics of high bioavailability of reactive oxygen species (ROS) and oxidative stress, chronic/persistent inflammation, glycation, and mitochondrial abnormalities. Excessive ROS production results...
9.
Leyane T, Jere S, Houreld N
Int J Mol Sci
. 2021 Oct;
22(20).
PMID: 34681882
Photobiomodulation (PBM) imparts therapeutically significant benefits in the healing of chronic wounds. Chronic wounds develop when the stages of wound healing fail to progress in a timely and orderly frame,...
10.
Rajendran N, George B, Houreld N, Abrahamse H
Molecules
. 2021 Jun;
26(10).
PMID: 34069558
Recently, the biosynthesis of zinc oxide nanoparticles (ZnO NPs) from crude extracts and phytochemicals has attracted much attention. Green synthesis of NPs is cost-effective, eco-friendly, and is a promising alternative...